These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. Delezé M; Oria CV; Alarcón-Segovia D J Rheumatol; 1988 Apr; 15(4):611-5. PubMed ID: 3274208 [TBL] [Abstract][Full Text] [Related]
9. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Bladt V; Steengaard-Pedersen K; Poulsen LH; Petersen OB; Laursen B; d'Amore F Eur J Haematol; 2004 Dec; 73(6):437-40. PubMed ID: 15522067 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Espinosa G; Bucciarelli S; Cervera R; Lozano M; Reverter JC; de la Red G; Gil V; Ingelmo M; Font J; Asherson RA Ann Rheum Dis; 2004 Jun; 63(6):730-6. PubMed ID: 15140782 [TBL] [Abstract][Full Text] [Related]
11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
12. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Kumar S; Benseler SM; Kirby-Allen M; Silverman ED Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962 [TBL] [Abstract][Full Text] [Related]
13. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient. Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042 [TBL] [Abstract][Full Text] [Related]
14. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904 [TBL] [Abstract][Full Text] [Related]
15. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. Delezé M; Alarcón-Segovia D; Oria CV; Sánchez-Guerrero J; Fernández-Dominguez L; Gomez-Pacheco L; Ponce de León S J Rheumatol; 1989 Jul; 16(7):926-30. PubMed ID: 2769665 [TBL] [Abstract][Full Text] [Related]
16. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review. de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254 [TBL] [Abstract][Full Text] [Related]
17. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188 [TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukaemia in a child with systemic lupus erythematosus. Gokce M; Bulus D; Bilginer Y; Gumruk F; Besbas N; Cetin M Lupus; 2012 Jul; 21(8):910-3. PubMed ID: 22331193 [TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Espinosa G; Bucciarelli S; Asherson RA; Cervera R Semin Thromb Hemost; 2008 Apr; 34(3):290-4. PubMed ID: 18720310 [TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]